BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7191463)

  • 1. Serotonin neuroleptics change patterns of preovulatory secretion of luteinizing hormone in rats.
    Walker RF
    Life Sci; 1980 Sep; 27(12):1063-8. PubMed ID: 7191463
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of ovulation in rats by antagonists to serotonin and by a new tricyclic compound.
    Markó M; Flückiger E
    Experientia; 1976 Apr; 32(4):491-2. PubMed ID: 1269657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract]   [Full Text] [Related]  

  • 4. On the central anti-serotoninergic actions of cyproheptadine and methysergide.
    Jacoby JH; Poulakos JJ; Bryce GF
    Neuropharmacology; 1978; 17(4-5):299-306. PubMed ID: 652142
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotoninergic inhibition of LH secretion in the domestic fowl.
    Hall TR; Cheung A; Harvey S
    J Endocrinol; 1986 Aug; 110(2):239-44. PubMed ID: 2943849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate-serotonin synergism stimulating luteinizing hormone release in estrogen-progesterone-primed ovariectomized rats: mediation by serotonin2 receptors.
    Lenahan SE; Seibel HR; Johnson JH
    Endocrinology; 1987 Apr; 120(4):1498-502. PubMed ID: 3830057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of parachlorophenylalanine, quipazine and cyproheptadine on growth hormone and adrenocorticotropin secretion in steers.
    Sartin JL; Kemppainen RJ; Marple DN; Carnes R; Dieberg G; Oliver EH
    Domest Anim Endocrinol; 1987 Jan; 4(1):33-41. PubMed ID: 2853663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities between the pharmacological actions of quipazine and serotonin.
    Hong E; Sancilio LF; Vargas R; Pardo EG
    Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of serotonin on spontaneous ovulation: a theory for the dual hypothalamic control of ovulation.
    Labhsetwar AP
    Acta Endocrinol (Copenh); 1971 Oct; 68(2):334-44. PubMed ID: 5171469
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine.
    Mendelson SD; Gorzalka BB
    Life Sci; 1986 Jan; 38(1):33-9. PubMed ID: 2934598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1979 Oct; 58(4):505-9. PubMed ID: 510385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous infusion of a steroid anaesthetic on the preovulatory surge of luteinizing hormone and ovulation in intact rats.
    Rabii J; Clifton DK; Sawyer CH
    J Endocrinol; 1978 Feb; 76(2):361-2. PubMed ID: 564387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.